Differentiation and function of Th17 T cells

Current Opinion in Immunology

Volumn 19, Issue 3, 2007, Pages 281-286

  Stockinger, Brigitta ^a   Veldhoen, Marc ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 23; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

AUTOIMMUNITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; CITROBACTER RODENTIUM; EFFECTOR CELL; HOST RESISTANCE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNITY; CELL DIFFERENTIATION; HUMANS; INTERLEUKIN-17; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 34247555353     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2007.04.005     Document Type: Review

References (49)

1. Kolls J.K., and Linden A. Interleukin-17 family members and inflammation. Immunity 21 (2004) 467-476
2. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6 (2005) 1123-1132
3. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6 (2005) 1133-1141
4. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., and Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201 (2005) 233-240
5. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., and Stockinger B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006) 179-189. This article identifies the crucial factors necessary for differentiation of Th17 T cells from naïve CD4 T-cell precursors, and rules out IL-23 as a differentiation factor.
6. H17 and regulatory T cells. Nature 441 (2006) 235-238. This article shows that in vitro Treg formation in the presence of TGF-β is subverted to Th17 generation in the presence of IL-6. Transgenic overexpression of TGF-β increases symptoms of EAE and numbers of Th17 T cells.
7. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., and Weaver C.T. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 (2006) 231-234. This article also shows the divergent effects of TGF-β depending upon the presence of IL-6. It furthermore shows that IL-23 is necessary to maintain Th17 effector function against an intestinal bacterial pathogen.
8. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., and Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278 (2003) 1910-1914
9. Murphy C.A., Langrish C.L., Chen Y., Blumenschein W., McClanahan T., Kastelein R.A., Sedgwick J.D., and Cua D.J. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198 (2003) 1951-1957
10. + T helper cells. Cell 126 (2006) 1121-1133. This article identifies the key transcription factor that defines the Th17 T-cell lineage to be the orphan nuclear receptor RORγ.
11. Sutton C., Brereton C., Keogh B., Mills K.H., and Lavelle E.C. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 203 (2006) 1685-1691
12. Labow M., Shuster D., Zetterstrom M., Nunes P., Terry R., Cullinan E.B., Bartfai T., Solorzano C., Moldawer L.L., Chizzonite R., et al. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J Immunol 159 (1997) 2452-2461
13. Satoskar A.R., Okano M., Connaughton S., Raisanen-Sokolwski A., David J.R., and Labow M. Enhanced Th2-like responses in IL-1 type 1 receptor-deficient mice. Eur J Immunol 28 (1998) 2066-2074
14. Chen Z., Laurence A., Kanno Y., Pacher-Zavisin M., Zhu B.M., Tato C., Yoshimura A., Hennighausen L., and O'Shea J.J. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc Natl Acad Sci USA 103 (2006) 8137-8142
15. •] highlight an important negative feedback regulation of Th17 T cells by IL-27. IL-27 inhibits in vitro differentiation of Th17 T cells, and its absence in IL-27-deficient mice exacerbates autoimmune pathology in the nervous system.
16. •].
17. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886
18. - T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172 (2004) 5149-5153
19. Wan Y.Y., and Flavell R.A. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci USA 102 (2005) 5126-5131
20. + regulatory T cells. J Exp Med 201 (2005) 737-746
21. + T cell-mediated suppression by dendritic cells. Science 299 (2003) 1033-1036
22. + regulatory T cells responsible for protection against diabetes. Proc Natl Acad Sci USA 101 (2004) 4572-4577
23. + T-cell pool and the expression of Foxp3 in vivo. Int Immunol 16 (2004) 1241-1249
24. Nakae S., Saijo S., Horai R., Sudo K., Mori S., and Iwakura Y. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci USA 100 (2003) 5986-5990
25. Cho M.L., Kang J.W., Moon Y.M., Nam H.J., Jhun J.Y., Heo S.B., Jin H.T., Min S.Y., Ju J.H., Park K.S., et al. STAT3 and NF-κB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J Immunol 176 (2006) 5652-5661
26. Chen Y., Langrish C.L., McKenzie B., Joyce-Shaikh B., Stumhofer J.S., McClanahan T., Blumenschein W., Churakovsa T., Low J., Presta L., et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 116 (2006) 1317-1326
27. Liang S.C., Tan X.-Y., Luxenberg D.P., Karim R., Danussi-Joannopoulos K., Collins M., and Fouser L.A. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203 (2006) 2271-2279. This article identifies IL-22 as a Th17-derived cytokine that is important in the innate response to skin infections. IL-22 production is upregulated by IL-23, establishing yet another function for this cytokine in the control of Th17 effector function.
28. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., and Sabat R. IL-22 increases the innate immunity of tissues. Immunity 21 (2004) 241-254
29. Veldhoen M., Hocking R.J., Flavell R.A., and Stockinger B. Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat Immunol 7 (2006) 1151-1156. This article establishes the obligatory role for TGF-β signalling in T cells for development of EAE, but also shows that chronic inflammation is required for autoimmune pathology. Certain pathogen-derived molecules such as zymosan can activate Th17 and initiate EAE but cannot sustain ongoing inflammation. As a consequence, autoimmune pathology is reversed.
30. Gorelik L., and Flavell R.A. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12 (2000) 171-181
31. Marie J.C., Liggitt D., and Rudensky A.Y. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-β receptor. Immunity 25 (2006) 441-454
32. Li M.O., Sanjabi S., and Flavell R.A. Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25 (2006) 455-471
33. Ohshima S., Saeki Y., Mima T., Sasai M., Nishioka K., Nomura S., Kopf M., Katada Y., Tanaka T., Suemura M., et al. Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc Natl Acad Sci USA 95 (1998) 8222-8226
34. Samoilova E.B., Horton J.L., Hilliard B., Liu T.S., and Chen Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J Immunol 161 (1998) 6480-6486
35. Lubberts E., Koenders M.I., Oppers-Walgreen B., van den Bersselaar L., Coenen-de Roo C.J., Joosten L.A., and van den Berg W.B. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50 (2004) 650-659
36. Uyttenhove C., and Van Snick J. Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis. Eur J Immunol 36 (2006) 2868-2874
37. Sonderegger I., Rohn T.A., Kurrer M.O., Iezzi G., Zou Y., Kastelein R.A., Bachmann M.F., and Kopf M. Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis. Eur J Immunol 36 (2006) 2849-2856
38. Rohn T.A., Jennings G.T., Hernandez M., Grest P., Beck M., Zou Y., Kopf M., and Bachmann M.F. Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur J Immunol 36 (2006) 2857-2867
39. Gutcher I., Urich E., Wolter K., Prinz M., and Becher B. Interleukin 18-independent engagement of interleukin 18 receptor-α is required for autoimmune inflammation. Nat Immunol 7 (2006) 946-953
40. Fossiez F., Banchereau J., Murray R., Van Kooten C., Garrone P., and Lebecque S. Interleukin-17. Int Rev Immunol 16 (1998) 541-551
41. McKenzie B.S., Kastelein R.A., and Cua D.J. Understanding the IL-23-IL-17 immune pathway. Trends Immunol 27 (2006) 17-23
42. Happel K.I., Dubin P.J., Zheng M., Ghilardi N., Lockhart C., Quinton L.J., Odden A.R., Shellito J.E., Bagby G.J., Nelson S., et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 202 (2005) 761-769
43. + T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol 170 (2003) 1958-1963
44. Huang W., Na L., Fidel P.L., and Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190 (2004) 624-631
45. Infante-Duarte C., Horton H.F., Byrne M.C., and Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 165 (2000) 6107-6115
46. Burchill M.A., Nardelli D.T., England D.M., DeCoster D.J., Christopherson J.A., Callister S.M., and Schell R.F. Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi. Infect Immun 71 (2003) 3437-3442
47. Yoshitomi H., Sakaguchi N., Kobayashi K., Brown G.D., Tagami T., Sakihama T., Hirota K., Tanaka S., Nomura T., Miki I., et al. A role for fungal β-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J Exp Med 201 (2005) 949-960
48. Du Z., Kelly E., Mecklenbrauker I., Agle L., Herrero C., Paik P., and Ivashkiv L.B. Selective regulation of IL-10 signaling and function by zymosan. J Immunol 176 (2006) 4785-4792
49. Dillon S., Agrawal S., Banerjee K., Letterio J., Denning T.L., Oswald-Richter K., Kasprowicz D.J., Kellar K., Pare J., van Dyke T., et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J Clin Invest 116 (2006) 916-928